TANDALAYA TRAYLOR: Open Payments
NPI 1578851325 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 42 payments from 13 companies in 2025. Trend: 2023 $326 · 2024 $491 · 2025 $1,830
Food & beverage: $1,135Travel & lodging: $695
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $1,039 |
| Novo Nordisk Inc | 5 | $152 |
| Sequel Med Tech, LLC | 6 | $139 |
| Corcept Therapeutics | 6 | $112 |
| PFIZER INC. | 1 | $85 |
| RGH Enterprises LLC | 2 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Dexcom, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
Products named: MINIMED 780G, TWIIST, Korlym, ZAVZPRET, FARXIGA, Dexcom G6 Transmitter, Ozempic, MOUNJARO.
Industry payments across MS — which companies pay providers there.
